Home  |  Contact

Cellosaurus UCRU-BL-17 (CVCL_M007)

[Text version]

Cell line name UCRU-BL-17
Synonyms UCRU-BL-17-CL; UCRU-BL-17CL; UCRU BL 17CL; UCRU-BL 17; BL-17; BL17
Accession CVCL_M007
Resource Identification Initiative To cite this cell line use: UCRU-BL-17 (RRID:CVCL_M007)
Disease Bladder carcinoma (NCIt: C4912)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_M008 (UCRU-BL-23)
Sex of cell Female
Age at sampling 69Y
Category Cancer cell line

Russell P.J., Raghavan D., Gregory P., Philips J., Wills E.J., Jelbart M., Wass J., Zbroja R.A., Vincent P.C.
Bladder cancer xenografts: a model of tumor cell heterogeneity.
Cancer Res. 46:2035-2040(1986)

PubMed=3335421; DOI=10.1002/ijc.2910410115
Russell P.J., Jelbart M., Wills E., Singh S., Wass J., Wotherspoon J., Raghavan D.
Establishment and characterization of a new human bladder cancer cell line showing features of squamous and glandular differentiation.
Int. J. Cancer 41:74-82(1988)

PubMed=2685375; DOI=10.1016/S0022-5347(17)39172-3
Walker K.Z., Russell P.J., Kingsley E.A., Philips J., Raghavan D.
Detection of malignant cells in voided urine from patients with bladder cancer, a novel monoclonal assay.
J. Urol. 142:1578-1583(1989)

PubMed=2328200; DOI=10.1038/bjc.1990.81
Brown J.L., Russell P.J., Philips J., Wotherspoon J., Raghavan D.
Clonal analysis of a bladder cancer cell line: an experimental model of tumour heterogeneity.
Br. J. Cancer 61:369-376(1990)

PubMed=8635192; DOI=10.1007/BF01526554
Kingsley E.A., Carter T.E., Barrow K.D., Russell P.J.
Characterisation of the anti-bladder-cancer monoclonal antibody BLCA-8: identification of its antigen as a neutral glycolipid.
Cancer Immunol. Immunother. 41:348-354(1995)

PubMed=8873383; DOI=10.1007/BF00295899
Stadler W.M., Olopade O.I.
The 9p21 region in bladder cancer cell lines: large homozygous deletion inactivate the CDKN2, CDKN2B and MTAP genes.
Urol. Res. 24:239-244(1996)

Walker K.Z., Russell P.J.
Monoclonal antibodies which recognize malignant cells from bladder carcinomas.
Patent number US5622836, 22-Apr-1997

PubMed=9246190; DOI=10.1080/09553009714349
Ribeiro J.C.C., Barnetson A.R., Fisher R.J., Mameghan H., Russell P.J.
Relationship between radiation response and p53 status in human bladder cancer cells.
Int. J. Radiat. Biol. 72:11-20(1997)

PubMed=23401075; DOI=10.1002/path.4176
Guo Y., Chekaluk Y., Zhang J., Du J., Gray N.S., Wu C.-L., Kwiatkowski D.J.
TSC1 involvement in bladder cancer: diverse effects and therapeutic implications.
J. Pathol. 230:17-27(2013)

Other Wikidata; Q54989701
Polymorphism and mutation databases Cosmic; 735768
Cosmic; 928828
Cosmic; 1927311
Entry history
Entry creation06-May-2013
Last entry update07-Sep-2018
Version number8